Accelerate Diagnostics Q4 EPS $(0.89) Misses $(0.62) Estimate, Sales $3.03M Miss $3.45M Estimate
Portfolio Pulse from dijoy@benzinga.com
Accelerate Diagnostics (NASDAQ:AXDX) reported Q4 earnings with a loss of $(0.89) per share, missing the $(0.62) estimate, and sales of $3.03M, below the $3.45M estimate. This represents a 493.33% increase in losses and a 1.85% increase in sales year-over-year.
March 28, 2024 | 9:13 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Accelerate Diagnostics reported significantly wider losses and slightly increased sales in Q4, missing both EPS and sales estimates.
The significant miss in both earnings per share and sales estimates, coupled with a substantial year-over-year increase in losses, is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100